| Name | Title | Contact Details |
|---|
Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
A&M Instruments Inc is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Telemed Diagnostic Management Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The pioneering team at Surefire Medical is inventing the future for cancer care. We develop advanced liver cancer infusion systems that overcome the limitations of traditional tools and delivery methods. Clinical discoveries paired with new, precise technology arm physicians to harness infusion pressure and work with the body’s natural flow, targeting tumors with superior accuracy, control and protection. Our founders, a biomedical engineer and an Interventional Radiologist, established Surefire Medical to revolutionize cancer treatment. Our inventive device technology is designed by and for the IR community by a Colorado-based team of physicians, engineers and researchers. We seek clinical discoveries and create new technologies with one goal in mind: to deliver improved outcomes for cancer patients and their families.